Literature DB >> 9591839

Propentofylline potentiates induced ischemic tolerance in gerbil hippocampal neurons via adenosine receptor.

N Kawahara1, T Ide, N Saito, K Kawai, T Kirino.   

Abstract

The effect of propentofylline, an adenosine uptake inhibitor, on ischemic tolerance was investigated in the gerbil global ischemia model. Propentofylline was administered 24 hours after short preconditioning ischemia, and animals were subjected to 5-minute ischemia 24 hours thereafter. Propentofylline at a dose of 20 mg/kg intraperitoneally, but not at a dose of 10 mg/kg, significantly potentiated the protective effect of preconditioning ischemia in the CA1 hippocampal neurons. This effect was completely abolished by simultaneous administration of theophylline (20 mg/kg), an adenosine receptor blocker. This finding suggests the involvement of adenosine receptor for the development of ischemic tolerance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9591839     DOI: 10.1097/00004647-199805000-00002

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  4 in total

Review 1.  Ischemic tolerance as an active and intrinsic neuroprotective mechanism.

Authors:  R Anne Stetler; Feng Zhang; Collin Liu; Jun Chen
Journal:  Handb Clin Neurol       Date:  2009

Review 2.  Mitogen-activated protein kinases and cerebral ischemia.

Authors:  K Nozaki; M Nishimura; N Hashimoto
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.682

3.  Mechanisms and prospects of ischemic tolerance induced by cerebral preconditioning.

Authors:  Mohammad Iqbal Hossain Bhuiyan; Youn Jung Kim
Journal:  Int Neurourol J       Date:  2010-12-31       Impact factor: 2.835

4.  Salvianolic acid B and danshensu induce osteogenic differentiation of rat bone marrow stromal stem cells by upregulating the nitric oxide pathway.

Authors:  Xinle Zhang; Liyi Zou; Jin Li; Bilian Xu; Tie Wu; Huanqiong Fan; Weiming Xu; Weimin Yao; Yajun Yang; Yuyu Liu; Liao Cui
Journal:  Exp Ther Med       Date:  2017-08-09       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.